menu
    • menu

    Company profile for Cereno Scientific

    NEW Drugs in Dev: 5
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Cereno Scientific is a clinical-stage biotech company developing better treatments for common and rare cardiovascular diseases. Cereno Scientific is a clinical-stage biotech company within common and rare cardiovascular disease. The experienced team at Cereno is dedicated to improve the health of patients with conditions that have high unmet needs, such as conditions with thrombosis, fibrosis, high pressure and inflammation. T...
    Cereno Scientific is a clinical-stage biotech company developing better treatments for common and rare cardiovascular diseases. Cereno Scientific is a clinical-stage biotech company within common and rare cardiovascular disease. The experienced team at Cereno is dedicated to improve the health of patients with conditions that have high unmet needs, such as conditions with thrombosis, fibrosis, high pressure and inflammation. The project portfolio comprises a Phase II program and two preclinical programs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Cereno ScientificSweden Flag
    Country
    Country
    Sweden
    Address
    Address
    BioVentureHub Pepparedsleden 1 431 83 Mölndal, Sverige
    Telephone
    Telephone
    556890–4071
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://cerenoscientific.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/cereno-scientific-ab/?originalSubdomain=se
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/cerenosciab

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cereno Publishes 1st Peer-Reviewed Study On HDAC Inhibitor CS014
    Cereno Publishes 1st Peer-Reviewed Study On HDAC Inhibitor CS014

    14 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/cereno-scientific-announces-first-peer-reviewed-publication-on-hdac-inhibitor-cs014-antithrombotic-efficacy-without-bleeding-risk-supports-broad-potential-in-cardiopulmonary-diseases-302661164.html

    PR NEWSWIRE
    14 Jan 2026
    Share Share
    Cereno to Attend JPM Week & Biotech Showcase in San Francisco
    Cereno to Attend JPM Week & Biotech Showcase in San Francisco

    12 Dec 2025

    // PR NEWSWIRE BIO

    https://www.prnewswire.com/news-releases/cereno-scientific-to-attend-jpm-week-and-biotech-showcase-in-san-francisco-us-on-january-12-18-2026-302639988.html

    PR NEWSWIRE BIO
    12 Dec 2025
    Share Share
    Cereno Scientific Cleared For Global Phase IIb Trial Of CS1
    Cereno Scientific Cleared For Global Phase IIb Trial Of CS1

    09 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/cereno-scientific-receives-fda-clearance-to-initiate-global-phase-iib-trial-of-cs1-in-pulmonary-arterial-hypertension-pah-302635815.html

    PR NEWSWIRE
    09 Dec 2025
    Share Share
    Cereno Scientific Submits CS1 Phase Iib Protocol For PAH To FDA
    Cereno Scientific Submits CS1 Phase Iib Protocol For PAH To FDA

    10 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/cereno-scientific-submits-phase-iib-trial-protocol-for-cs1-in-pulmonary-arterial-hypertension-pah-to-the-us-fda-302609911.html

    PR NEWSWIRE
    10 Nov 2025
    Share Share
    Cereno's HDAC inhibitor reduces risks from PAH in phase 2 trial
    Cereno's HDAC inhibitor reduces risks from PAH in phase 2 trial

    30 Sep 2024

    // James Waldron FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/cerenos-hdac-inhibitor-reduces-risks-pulmonary-arterial-hypertension-phase-2-trial

    James Waldron FIERCE BIOTECH
    30 Sep 2024
    Share Share
    Cereno Scientific obtains first patent in Europe for drug candidate CS585
    Cereno Scientific obtains first patent in Europe for drug candidate CS585

    23 Sep 2022

    // CISION

    https://news.cision.com/cereno-scientific/r/cereno-scientific-obtains-first-patent-in-europe-for-drug-candidate-cs585,c3635866

    CISION
    23 Sep 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search